Jiangxi Changnuo Pharmaceutical

Jiangxi Changnuo Pharmaceutical is a China-based pharmaceutical company headquartered in Nanchang, specializing in the research, development, and production of chemical drug preparations and active pharmaceutical ingredients (APIs). The company's product portfolio is heavily focused on anti-infective agents, including a variety of cephalosporin and macrolide antibiotics. In addition to its strength in infectious diseases, Jiangxi Changnuo produces treatments for chronic conditions such as hypertension and type 2 diabetes. The firm operates manufacturing facilities that comply with national Good Manufacturing Practice (GMP) standards, ensuring the quality of its generic drug offerings. By integrating R&D with large-scale production, the company serves both the domestic Chinese healthcare market and international clients. Jiangxi Changnuo is also actively involved in the consistency evaluation of generic drugs to maintain competitiveness in the evolving regulatory landscape.